Home › IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment
 

Keywords :   


IntelliCyt And FIMM Announce A Collaboration To Advance Personalized Medicine In Cancer Treatment

2016-03-02 05:45:22| drugdiscoveryonline Home Page

IntelliCyt, a leading provider of integrated platforms that accelerate drug discovery, antibody screening and immuno-oncology research today announced a collaboration with the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki to further the development of personalized medicine in cancer treatment

Tags: treatment medicine advance cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Five more San Antonio TV stations launch NEXTGEN TV
15.05Liberty Latin America organic Video RGUs up 2,000 in 1Q 2024
15.05Dine and dash couple hit my pizzeria, says owner
15.05Boeing may face criminal prosecution, US says
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
More »